Click for best price
RNA In Situ Hybridization Market Size, Share 2022
This report contains market size and forecasts of RNA In Situ Hybridization in Global, including the following market information:
Global RNA In Situ Hybridization Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global RNA In Situ Hybridization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GISH Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA In Situ Hybridization include Abbott, Biogenex, Biosb, Roche, Sigma-Aldrich, Advanced Cell Diagnostics, Affymetrix, Exiqon and Agilent Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA In Situ Hybridization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA In Situ Hybridization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Type, 2021 (%)
GISH
FISH
mFISH
PCR
Global RNA In Situ Hybridization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNA In Situ Hybridization Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pharma & Biotech Companies
Research Labs
CROs
Global RNA In Situ Hybridization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNA In Situ Hybridization Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA In Situ Hybridization revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies RNA In Situ Hybridization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Biogenex
Biosb
Roche
Sigma-Aldrich
Advanced Cell Diagnostics
Affymetrix
Exiqon
Agilent Technologies
Thermo Fisher Scientific
| Report Attributes |
Report Details |
| Report Title |
RNA In Situ Hybridization Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA In Situ Hybridization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA In Situ Hybridization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA In Situ Hybridization Overall Market Size
2.1 Global RNA In Situ Hybridization Market Size: 2021 VS 2028
2.2 Global RNA In Situ Hybridization Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA In Situ Hybridization Players in Global Market
3.2 Top Global RNA In Situ Hybridization Companies Ranked by Revenue
3.3 Global RNA In Situ Hybridization Revenue by Companies
3.4 Top 3 and Top 5 RNA In Situ Hybridization Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNA In Situ Hybridization Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA In Situ Hybridization Players in Global Market
3.6.1 List of Global Tier 1 RNA In Situ Hybridization Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA In Situ Hybridization Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global RNA In Situ Hybridization Market Size Markets, 2021 & 2028
4.1.2 GISH
4.1.3 FISH
4.1.4 mFISH
4.1.5 PCR
4.2 By Type - Global RNA In Situ Hybridization Revenue & Forecasts
4.2.1 By Type - Global RNA In Situ Hybridization Revenue, 2017-2022
4.2.2 By Type - Global RNA In Situ Hybridization Revenue, 2023-2028
4.2.3 By Type - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA In Situ Hybridization Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Pharma & Biotech Companies
5.1.4 Research Labs
5.1.5 CROs
5.2 By Application - Global RNA In Situ Hybridization Revenue & Forecasts
5.2.1 By Application - Global RNA In Situ Hybridization Revenue, 2017-2022
5.2.2 By Application - Global RNA In Situ Hybridization Revenue, 2023-2028
5.2.3 By Application - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global RNA In Situ Hybridization Market Size, 2021 & 2028
6.2 By Region - Global RNA In Situ Hybridization Revenue & Forecasts
6.2.1 By Region - Global RNA In Situ Hybridization Revenue, 2017-2022
6.2.2 By Region - Global RNA In Situ Hybridization Revenue, 2023-2028
6.2.3 By Region - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America RNA In Situ Hybridization Revenue, 2017-2028
6.3.2 US RNA In Situ Hybridization Market Size, 2017-2028
6.3.3 Canada RNA In Situ Hybridization Market Size, 2017-2028
6.3.4 Mexico RNA In Situ Hybridization Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe RNA In Situ Hybridization Revenue, 2017-2028
6.4.2 Germany RNA In Situ Hybridization Market Size, 2017-2028
6.4.3 France RNA In Situ Hybridization Market Size, 2017-2028
6.4.4 U.K. RNA In Situ Hybridization Market Size, 2017-2028
6.4.5 Italy RNA In Situ Hybridization Market Size, 2017-2028
6.4.6 Russia RNA In Situ Hybridization Market Size, 2017-2028
6.4.7 Nordic Countries RNA In Situ Hybridization Market Size, 2017-2028
6.4.8 Benelux RNA In Situ Hybridization Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia RNA In Situ Hybridization Revenue, 2017-2028
6.5.2 China RNA In Situ Hybridization Market Size, 2017-2028
6.5.3 Japan RNA In Situ Hybridization Market Size, 2017-2028
6.5.4 South Korea RNA In Situ Hybridization Market Size, 2017-2028
6.5.5 Southeast Asia RNA In Situ Hybridization Market Size, 2017-2028
6.5.6 India RNA In Situ Hybridization Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America RNA In Situ Hybridization Revenue, 2017-2028
6.6.2 Brazil RNA In Situ Hybridization Market Size, 2017-2028
6.6.3 Argentina RNA In Situ Hybridization Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA In Situ Hybridization Revenue, 2017-2028
6.7.2 Turkey RNA In Situ Hybridization Market Size, 2017-2028
6.7.3 Israel RNA In Situ Hybridization Market Size, 2017-2028
6.7.4 Saudi Arabia RNA In Situ Hybridization Market Size, 2017-2028
6.7.5 UAE RNA In Situ Hybridization Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott RNA In Situ Hybridization Major Product Offerings
7.1.4 Abbott RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Biogenex
7.2.1 Biogenex Corporate Summary
7.2.2 Biogenex Business Overview
7.2.3 Biogenex RNA In Situ Hybridization Major Product Offerings
7.2.4 Biogenex RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.2.5 Biogenex Key News
7.3 Biosb
7.3.1 Biosb Corporate Summary
7.3.2 Biosb Business Overview
7.3.3 Biosb RNA In Situ Hybridization Major Product Offerings
7.3.4 Biosb RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.3.5 Biosb Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche RNA In Situ Hybridization Major Product Offerings
7.4.4 Roche RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Sigma-Aldrich
7.5.1 Sigma-Aldrich Corporate Summary
7.5.2 Sigma-Aldrich Business Overview
7.5.3 Sigma-Aldrich RNA In Situ Hybridization Major Product Offerings
7.5.4 Sigma-Aldrich RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.5.5 Sigma-Aldrich Key News
7.6 Advanced Cell Diagnostics
7.6.1 Advanced Cell Diagnostics Corporate Summary
7.6.2 Advanced Cell Diagnostics Business Overview
7.6.3 Advanced Cell Diagnostics RNA In Situ Hybridization Major Product Offerings
7.6.4 Advanced Cell Diagnostics RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.6.5 Advanced Cell Diagnostics Key News
7.7 Affymetrix
7.7.1 Affymetrix Corporate Summary
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix RNA In Situ Hybridization Major Product Offerings
7.7.4 Affymetrix RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.7.5 Affymetrix Key News
7.8 Exiqon
7.8.1 Exiqon Corporate Summary
7.8.2 Exiqon Business Overview
7.8.3 Exiqon RNA In Situ Hybridization Major Product Offerings
7.8.4 Exiqon RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.8.5 Exiqon Key News
7.9 Agilent Technologies
7.9.1 Agilent Technologies Corporate Summary
7.9.2 Agilent Technologies Business Overview
7.9.3 Agilent Technologies RNA In Situ Hybridization Major Product Offerings
7.9.4 Agilent Technologies RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.9.5 Agilent Technologies Key News
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Corporate Summary
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific RNA In Situ Hybridization Major Product Offerings
7.10.4 Thermo Fisher Scientific RNA In Situ Hybridization Revenue in Global Market (2017-2022)
7.10.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA In Situ Hybridization Market Opportunities & Trends in Global Market
Table 2. RNA In Situ Hybridization Market Drivers in Global Market
Table 3. RNA In Situ Hybridization Market Restraints in Global Market
Table 4. Key Players of RNA In Situ Hybridization in Global Market
Table 5. Top RNA In Situ Hybridization Players in Global Market, Ranking by Revenue (2021)
Table 6. Global RNA In Situ Hybridization Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global RNA In Situ Hybridization Revenue Share by Companies, 2017-2022
Table 8. Global Companies RNA In Situ Hybridization Product Type
Table 9. List of Global Tier 1 RNA In Situ Hybridization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA In Situ Hybridization Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - RNA In Situ Hybridization Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global RNA In Situ Hybridization Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global RNA In Situ Hybridization Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global RNA In Situ Hybridization Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America RNA In Situ Hybridization Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe RNA In Situ Hybridization Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America RNA In Situ Hybridization Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa RNA In Situ Hybridization Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott RNA In Situ Hybridization Product Offerings
Table 32. Abbott RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 33. Biogenex Corporate Summary
Table 34. Biogenex RNA In Situ Hybridization Product Offerings
Table 35. Biogenex RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 36. Biosb Corporate Summary
Table 37. Biosb RNA In Situ Hybridization Product Offerings
Table 38. Biosb RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche RNA In Situ Hybridization Product Offerings
Table 41. Roche RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 42. Sigma-Aldrich Corporate Summary
Table 43. Sigma-Aldrich RNA In Situ Hybridization Product Offerings
Table 44. Sigma-Aldrich RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 45. Advanced Cell Diagnostics Corporate Summary
Table 46. Advanced Cell Diagnostics RNA In Situ Hybridization Product Offerings
Table 47. Advanced Cell Diagnostics RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 48. Affymetrix Corporate Summary
Table 49. Affymetrix RNA In Situ Hybridization Product Offerings
Table 50. Affymetrix RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 51. Exiqon Corporate Summary
Table 52. Exiqon RNA In Situ Hybridization Product Offerings
Table 53. Exiqon RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 54. Agilent Technologies Corporate Summary
Table 55. Agilent Technologies RNA In Situ Hybridization Product Offerings
Table 56. Agilent Technologies RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
Table 57. Thermo Fisher Scientific Corporate Summary
Table 58. Thermo Fisher Scientific RNA In Situ Hybridization Product Offerings
Table 59. Thermo Fisher Scientific RNA In Situ Hybridization Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. RNA In Situ Hybridization Segment by Type in 2021
Figure 2. RNA In Situ Hybridization Segment by Application in 2021
Figure 3. Global RNA In Situ Hybridization Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA In Situ Hybridization Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA In Situ Hybridization Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA In Situ Hybridization Revenue in 2021
Figure 8. By Type - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 9. By Application - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 10. By Region - Global RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 11. By Country - North America RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 12. US RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 13. Canada RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 16. Germany RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 17. France RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 19. Italy RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 20. Russia RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 24. China RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 25. Japan RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 28. India RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 30. Brazil RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa RNA In Situ Hybridization Revenue Market Share, 2017-2028
Figure 33. Turkey RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 34. Israel RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 36. UAE RNA In Situ Hybridization Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Biogenex RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biosb RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sigma-Aldrich RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Advanced Cell Diagnostics RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Affymetrix RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Exiqon RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Agilent Technologies RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Thermo Fisher Scientific RNA In Situ Hybridization Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
